secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2025-02-14T23:59:59+00:00
Accession:  0001104659-25-013467
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie appoints CEO Robert Michael as Chairman, Gonzalez to retire July 1, 2025
-------------------------------------------------------------------------------

- CEO Robert A. Michael unanimously elected Chairman, effective July 1, 2025.
- Chairman Richard A. Gonzalez retires from board effective July 1, 2025; served as Chairman since AbbVie's 2013 formation.
- Director Glenn F. Tilton also retires from board effective July 1, 2025; lead independent director from 2013 to 2024.
- Michael continues as CEO and assumes additional role of Chairman.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/0001104659-25-013467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/tm256372d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-013467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer